Skip to main content
Skip to recall details
Verified · FDAClass II — Possible RiskMedications

Harbin Jixianglong Biotech Co., Ltd. Semaglutide, For Rx compounding use only Recall 2026

Harbin Jixianglong Biotech Co., Ltd.Issued February 13, 2026Updated Reviewed by the Recall Watch editorial team

Harbin Jixianglong Biotech Co., Ltd. Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 8438 — recalled per FDA on 2/13/2026. Reason: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution.

Agency
FDA
Issued
Feb 13, 2026
Brand
Harbin Jixianglong Biotech Co., Ltd.
Distribution
1 states
Lots affected
5
What to do right now

Steps to take for this recall

  1. Stop using it

    Take it out of rotation. Don't consume, wear, or operate.

  2. Verify the match

    Compare lot numbers, UPCs, and dates against your product.

  3. Return or dispose

    Follow the manufacturer's instructions to refund or safely dispose.

Free case review

Were you or someone in your household prescribed this medication?

  • Free
  • No obligation
  • Licensed attorneys
Attorney advertising.Details

Recall Watch is not a law firm and does not provide legal or medical advice. Free case reviews are provided by independent licensed attorneys; Recall Watch may receive a referral fee. Prior results do not guarantee a similar outcome. Submitting this form does not create an attorney-client relationship. See our terms and privacy policy.

Verified summary of the official U.S. Food and Drug Administration notice · Issued February 13, 2026 · Last synced Nov 1, 2026

What's recalled

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China.

Available at AmazonAd
White first-aid box with bandages

Restock your medicine cabinet

First-aid kits, thermometers and OTC basics, searched on Amazon.

Shop at Amazon.com

Need it delivered? Start a free Amazon Prime trial.

Why it was recalled

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Affected products & lot numbers
5 lots called out

Affected Lot Numbers

Check your product label — do not use if your lot number appears below.

Lot Number
Batch # CP-030-20250911
Mfg Date: Sep. 25th
2025
Retest Date: Sep. 24th
2027.
Where was it sold
1 state

Nationwide within the United States

nationwide
Official noticefda.gov
More recalls like this
5 related — by brand, contaminant, and category

Frequently asked questions

Is the Harbin Jixianglong Biotech Co., Ltd. recall still active?

Yes, this recall is currently active as of February 13, 2026. Do not use or consume the affected product.

What lot numbers are affected?

Affected lot numbers: Batch # CP-030-20250911, Mfg Date: Sep. 25th, 2025, Retest Date: Sep. 24th, 2027.. Check the label on your product.

What should I do if I have the recalled Harbin Jixianglong Biotech Co., Ltd.?

Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.